Enrolling women into HIV preventive vaccine trials: An ethical imperative but a logistical challenge
2006

Enrolling Women in HIV Vaccine Trials: Challenges and Solutions

publication Evidence: moderate

Author Information

Author(s): Edward Mills, Stephanie Nixon, Sonal Singh, Sonam Dolma, Anjali Nayyar, Sushma Kapoor

Primary Institution: McMaster University

Hypothesis

The challenge of enrolling women into HIV vaccine trials must be overcome for trials to be ethical and valid.

Conclusion

To conduct valid HIV vaccine trials, it is essential to address the unique barriers women face in participating.

Supporting Evidence

  • Women represent nearly half of the 40.3 million HIV infections worldwide.
  • Barriers to women's participation in trials stem from lower social status and lack of decision-making rights.
  • Community involvement is crucial for addressing the unique needs of women in trials.

Takeaway

Women need to be included in HIV vaccine trials, but there are many challenges that make it hard for them to participate.

Potential Biases

Potential biases may arise from cultural and societal pressures affecting women's participation.

Limitations

The study does not provide specific data on the sample size or statistical analysis.

Participant Demographics

Women, particularly in developing countries, aged 15-49 years.

Digital Object Identifier (DOI)

10.1371/journal.pmed.0030094

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication